maintrac
MAINTRAC®
The Key to Personalised Cancer Therapy
maintrac® is an innovative blood test designed to detect circulating tumor cells — those responsible for the formation of metastases. Since cancer cells can change throughout the course of the disease, maintrac® enables precise monitoring of how the body responds to treatment.
By regularly measuring both the number and characteristics of these cells, physicians can make timely, informed decisions, adapting treatment strategies and selecting the most effective medications for each individual patient.
maintrac® supports the development of a personalised, targeted, and effective treatment plan, while continuously tracking therapeutic progress.
BEFORE, DURING, AND AFTER
CANCER THERAPY
Innovative Laboratory Diagnostics for the Best Possible Outcomes in Cancer Treatment
maintrac® provides valuable diagnostic insights at every stage of treatment: from initial planning to long-term follow-up, offering clinicians and patients the ability to respond proactively and individually to disease progression or therapeutic resistance.
 |
|
maintrac® CELL COUNTING |
|
Therapy Monitoring and Direct Observation of Residual Tumor Burden During and After Treatment |
 |
|
maintrac® DRUG SENSITIVITY TESTING |
|
Testing the Effectiveness of Drugs, Cytotoxic Agents, and Hyperthermia – Before and During Treatment |
 |
|
maintrac® THERAPY-RELEVANT CHARACTERISTICS |
|
Testing for Indicators of Therapy Response or Non-Response |
 |
| stemtrac® TUMOR SPHERES |
|
Testing Tumor Spheres to Assess the Risk of Metastasis and Tumor Aggressiveness |
When Is Testing with maintrac®Recommended?
- before treatment: to establish a baseline value
- during treatment: to evaluate the effectiveness of ongoing therapy and adjust it if necessary
- after treatment: to monitor for recurrence of the disease following therapy completion
- in cases of progression or resistance: to assess how the cancer responds to new treatments or to detect resistance early
The Benefits of MAINTRAC®
maintrac® can be used for all solid epithelial tumors and offers proven benefits.
Early Detection of Recurrence:
maintrac® can indicate a high likelihood
of cancer recurrence before clinical symptoms become apparent.
Therapy Monitoring:
maintrac® allows regular monitoring of circulating
tumor cell counts to show whether ongoing treatment is effective.
Individualised Therapy Adjustment:
maintrac® helps evaluate treatment
effectiveness, enabling early adaptation of therapies to optimise outcomes.
Non-Invasive Method:
maintrac® is based on a blood test, reducing the
need for invasive procedures to monitor the tumor.
The relevance of maintrac® diagnostics has been confirmed in 15 studies involving over 940 patients. You can find these and further publications on circulating tumor cells on the Publications.
ACCREDITED LABORATORY
ACCORDING TO DIN EN ISO 15189
maintrac®
Direct Detection
without Enrichment
Quantitative
Determination
of Living Cells
Blood Sampling |
|
|
15 ml of EDTA blood sample is drawn. |
Staining |
|
|
The blood is stained with specific antibodies to label tumor cells. |
Image Acquisition |
|
|
Using a fluorescence microscope, images of the stained tumor cells are captured. |
Analysis |
|
|
The cells are automatically analyzed for the presence of living circulating epithelial tumor cells (CETCs/CTCs). |
Report |
|
|
Based on the analysis, a report will be compiled illustrating the progression of circulating tumor cell counts. |
FAQ
The Most Frequently Asked Questions About maintrac® and Their Answers:
+ What is maintrac®?
- maintrac® is a diagnostic laboratory method for quantitative detection of circulating tumor cells in the blood. The resulting dynamic is used to develop informed statements about current and further treatment measures.
+ What benefits does maintrac® diagnostics offer patients?
- early detection of renewed tumor activity
- monitoring and adjustment of therapy
- long-term surveillance even after therapy completion
- testing of medications
+ How much does maintrac® diagnostics cost?
- maintrac® is covered as an individual health service (IGeL) by many private health insurers. Upon request, we can assist you with applying for cost coverage.
+ Can the course of the disease be monitored using maintrac®?
- By determining the cell count at regular intervals, tumor activity can be monitored before, during, and after the entire course of therapy. Since circulating tumor cells can remain inactive for extended periods, it is advisable to continue evaluating the cell count even after therapy has ended.
INFORMATION FOR DOWNLOAD
Our brochures and flyers available for you to download
174
scientific publications
}
MAINTRAC® Shipping Boxes
You can order our maintrac® shipping boxes free of charge. We are happy to assist you with this. Our new shipping containers maintain a stable room temperature during transport to our laboratory for a period of 48 to 72 hours.
